187 related articles for article (PubMed ID: 32445122)
1. Elevated intracranial pressure after head trauma can be suppressed by antisecretory factor-a pilot study.
Gatzinsky K; Johansson E; Jennische E; Oshalim M; Lange S
Acta Neurochir (Wien); 2020 Jul; 162(7):1629-1637. PubMed ID: 32445122
[TBL] [Abstract][Full Text] [Related]
2. Antisecretory factor (AF) exerts no effects on intracranial pressure (ICP) waves and ICP in patients with idiopathic normal pressure hydrocephalus and idiopathic intracranial hypertension.
Eide PK; Eidsvaag VA; Hansson HA
J Neurol Sci; 2014 Aug; 343(1-2):132-7. PubMed ID: 24928077
[TBL] [Abstract][Full Text] [Related]
3. Antisecretory Factor May Reduce ICP in Severe TBI-A Case Series.
Cederberg D; Hansson HA; Visse E; Siesjö P
Front Neurol; 2020; 11():95. PubMed ID: 32210902
[TBL] [Abstract][Full Text] [Related]
4. Effect of antisecretory factor, given as a food supplement to adult patients with severe traumatic brain injury (SASAT): protocol for an exploratory randomized double blind placebo-controlled trial.
Cederberg D; Harrington BM; Vlok AJ; Siesjö P
Trials; 2022 Apr; 23(1):340. PubMed ID: 35461285
[TBL] [Abstract][Full Text] [Related]
5. The peptide AF-16 and the AF protein counteract intracranial hypertension.
Hansson HA; Al-Olama M; Jennische E; Gatzinsky K; Lange S
Acta Neurochir Suppl; 2012; 114():377-82. PubMed ID: 22327727
[TBL] [Abstract][Full Text] [Related]
6. Salovum egg yolk containing antisecretory factor as an adjunct therapy in severe cholera in adult males: a pilot study.
Alam NH; Ashraf H; Olesen M; Salam MA; Gyr N; Meier R
J Health Popul Nutr; 2011 Aug; 29(4):297-302. PubMed ID: 21957667
[TBL] [Abstract][Full Text] [Related]
7. A novel step-down infusion method of barbiturate therapy: Its safety and effectiveness for intracranial pressure control.
Yamakawa Y; Morioka M; Negoto T; Orito K; Yoshitomi M; Nakamura Y; Takeshige N; Yamamoto M; Takeuchi Y; Oda K; Jono H; Saito H
Pharmacol Res Perspect; 2021 Apr; 9(2):e00719. PubMed ID: 33617150
[TBL] [Abstract][Full Text] [Related]
8. Role of Intracranial Pressure Monitoring in Management of Patients with Severe Traumatic Brain Injury: Results of a Large Level I Trauma Center in Southern Iran.
Khalili H; Sadraei N; Niakan A; Ghaffarpasand F; Sadraei A
World Neurosurg; 2016 Oct; 94():120-125. PubMed ID: 27392896
[TBL] [Abstract][Full Text] [Related]
9. Quantitative pupillometry for the monitoring of intracranial hypertension in patients with severe traumatic brain injury.
Jahns FP; Miroz JP; Messerer M; Daniel RT; Taccone FS; Eckert P; Oddo M
Crit Care; 2019 May; 23(1):155. PubMed ID: 31046817
[TBL] [Abstract][Full Text] [Related]
10. Pentobarbital coma for refractory intra-cranial hypertension after severe traumatic brain injury: mortality predictions and one-year outcomes in 55 patients.
Marshall GT; James RF; Landman MP; O'Neill PJ; Cotton BA; Hansen EN; Morris JA; May AK
J Trauma; 2010 Aug; 69(2):275-83. PubMed ID: 20699736
[TBL] [Abstract][Full Text] [Related]
11. Improved Pressure Equalization Ratio Following Mannitol Administration in Patients With Severe TBI: A Preliminary Study of a Potential Bedside Marker for Response to Therapy.
Doron O; Hemphill JC; Manley G; Rosenthal G
Neurocrit Care; 2022 Apr; 36(2):519-526. PubMed ID: 34498204
[TBL] [Abstract][Full Text] [Related]
12. The peptide AF-16 abolishes sickness and death at experimental encephalitis by reducing increase of intracranial pressure.
Jennische E; Bergström T; Johansson M; Nyström K; Tarkowski A; Hansson HA; Lange S
Brain Res; 2008 Aug; 1227():189-97. PubMed ID: 18586012
[TBL] [Abstract][Full Text] [Related]
13. Thiopental attenuates energetic impairment but fails to normalize cerebrospinal fluid glutamate in brain-injured patients.
Stover JF; Pleines UE; Morganti-Kossmann MC; Stocker R; Kossmann T
Crit Care Med; 1999 Jul; 27(7):1351-7. PubMed ID: 10446831
[TBL] [Abstract][Full Text] [Related]
14. Temporal effects of barbiturate coma on intracranial pressure and compensatory reserve in children with traumatic brain injury.
Velle F; Lewén A; Howells T; Nilsson P; Enblad P
Acta Neurochir (Wien); 2021 Feb; 163(2):489-498. PubMed ID: 33341913
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of 7.5% hypertonic saline in children with severe traumatic brain injury.
Rallis D; Poulos P; Kazantzi M; Chalkias A; Kalampalikis P
J Crit Care; 2017 Apr; 38():52-56. PubMed ID: 27838440
[TBL] [Abstract][Full Text] [Related]
16. Prediction of intracranial pressure crises after severe traumatic brain injury using machine learning algorithms.
Petrov D; Miranda SP; Balu R; Wathen C; Vaz A; Mohan V; Colon C; Diaz-Arrastia R
J Neurosurg; 2023 Aug; 139(2):528-535. PubMed ID: 36708534
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of Pharmacologic Therapeutic Agents Used for the Reduction of Intracranial Pressure After Traumatic Brain Injury.
Alnemari AM; Krafcik BM; Mansour TR; Gaudin D
World Neurosurg; 2017 Oct; 106():509-528. PubMed ID: 28712906
[TBL] [Abstract][Full Text] [Related]
18. First Intracranial Pressure Monitoring or First Operation: Which One Is Better?
Fu P; Yuan Q; Lv K; Hu J
World Neurosurg; 2020 Jan; 133():e105-e114. PubMed ID: 31479786
[TBL] [Abstract][Full Text] [Related]
19. An equiosmolar study on early intracranial physiology and long term outcome in severe traumatic brain injury comparing mannitol and hypertonic saline.
Jagannatha AT; Sriganesh K; Devi BI; Rao GS
J Clin Neurosci; 2016 May; 27():68-73. PubMed ID: 26924183
[TBL] [Abstract][Full Text] [Related]
20. Is there an upper limit of intracranial pressure in patients with severe head injury if cerebral perfusion pressure is maintained?
Young JS; Blow O; Turrentine F; Claridge JA; Schulman A
Neurosurg Focus; 2003 Dec; 15(6):E2. PubMed ID: 15305838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
